Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Down 8.7% in November

Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 6,210,000 shares, a drop of 8.7% from the October 31st total of 6,800,000 shares. Approximately 5.1% of the shares of the stock are short sold. Based on an average daily volume of 1,730,000 shares, the days-to-cover ratio is currently 3.6 days.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

Institutional Trading of Henry Schein

Several large investors have recently made changes to their positions in HSIC. Cromwell Holdings LLC lifted its holdings in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new position in Henry Schein in the 2nd quarter worth $31,000. Blue Trust Inc. lifted its position in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after purchasing an additional 1,100 shares during the period. Institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of recent research reports. Barrington Research restated an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. UBS Group cut their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Six equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.38.

Henry Schein Price Performance

Shares of HSIC opened at $76.50 on Tuesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market cap of $9.54 billion, a PE ratio of 31.48, a PEG ratio of 2.21 and a beta of 0.87. The firm’s 50 day moving average price is $71.57 and its 200 day moving average price is $69.88. Henry Schein has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up .4% on a year-over-year basis. During the same quarter last year, the firm earned $1.32 EPS. As a group, research analysts expect that Henry Schein will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.